Absci Corporation (ABSI)
NASDAQ: ABSI · Real-Time Price · USD
3.840
-0.110 (-2.78%)
Apr 21, 2026, 12:59 PM EDT - Market open
Absci Revenue
In the year 2025, Absci had annual revenue of $2.80M, down -38.24%. Absci had revenue of $650.00K in the quarter ending December 31, 2025, a decrease of -2.26%.
Revenue (ttm)
$2.80M
Revenue Growth
-38.24%
P/S Ratio
208.76
Revenue / Employee
$20,000
Employees
140
Market Cap
587.60M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.80M | -1.73M | -38.24% |
| Dec 31, 2024 | 4.53M | -1.18M | -20.71% |
| Dec 31, 2023 | 5.72M | -29.00K | -0.50% |
| Dec 31, 2022 | 5.75M | 965.00K | 20.18% |
| Dec 31, 2021 | 4.78M | 2.00K | 0.04% |
| Dec 31, 2020 | 4.78M | 2.72M | 132.04% |
| Dec 31, 2019 | 2.06M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Valneva SE | 205.07M |
| 4D Molecular Therapeutics | 85.21M |
| ADC Therapeutics | 81.36M |
| Fulcrum Therapeutics | 80.00M |
| Upstream Bio | 2.85M |
| Lyell Immunopharma | 36.00K |
ABSI News
- 13 days ago - Absci to Participate in the 25th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 27 days ago - Absci Reports Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results - GlobeNewsWire
- 6 weeks ago - Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 7 weeks ago - Absci Strengthens Clinical Leadership with Appointment of Ransi Somaratne, M.D., FACC, MBA as Chief Medical Officer - GlobeNewsWire
- 2 months ago - Absci to Report Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results on March 24, 2026 - GlobeNewsWire
- 2 months ago - Absci to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 4 months ago - Absci to Participate in the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 4 months ago - Absci Reports New Human Ex Vivo Data Demonstrating That ABS-201™ Stimulates Hair Growth and Regenerates Stem Cell Niche to Potentially Reverse Follicle Miniaturization - GlobeNewsWire